Author of the publication

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers

, , , , , , , , , , , , , , , , , and . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (35): 5887–5892 (2009)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk, , , , , , , , , and 4 other author(s). Breast cancer research and treatment, 118 (2): 407–413 (2009)Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers, , , , , , , , , and 99 other author(s). Human molecular genetics, 20 (23): 4732–4747 (2011)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity, , , , , , , , , and 17 other author(s). Human mutation, 31 (1): 60–66 (2010)A 14 nm 1.1 Mb Embedded DRAM Macro With 1 ns Access., , , , , , , , , and 12 other author(s). IEEE J. Solid State Circuits, 51 (1): 230-239 (2016)Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients, , , , , , , , , and 13 other author(s). International journal of cancer. Journal international du cancer, 126 (12): 2858–2862 (2010)Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers, , , , , , , , , and 171 other author(s). Breast cancer research : BCR, 14 (1): R33 (2012)Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 127 other author(s). Human molecular genetics, 18 (22): 4442–4456 (2009)GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma, , , , , , , , , and 7 other author(s). British journal of haematology, 144 (3): 317–331 (2009)Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma, , , , , , , , , and 4 other author(s). Haematologica, 93 (6): 949–950 (2008)